.
Purpose
The presence of distant metastases is one of the most powerful predictors of outcome in patients with neuroblastoma. However, the pattern of metastic spread is not incorporated into current risk stratification systems. Small case series have suggested that patients with neuroblastoma who have metastic disease limited to distant lymph nodes (4N disease) may have improved outcomes.
Patients and Methods
We analyzed retrospective data from the International Neuroblastoma Risk Group database for patients diagnosed from 1990 to 2002. 4N patients were compared with the remaining stage 4 patients (non-4N), excluding those with missing metastic site data.
Results
In all, 2,250 International Neuroblastoma Staging System stage 4 patients with complete data were identified, of whom 146 (6.5%) had 4N disease. For 4N patients, event-free survival (EFS; 5-year, 77% + 4%) and overall survival (OS; 5-year, 85% + 3%) were significantly better than EFS (5-year, 35% + 1%) and OS (5-year, 42% + 1%) for non-4N stage 4 patients (P< .001). 4N patients were more likely to be younger (P < .001) and have tumors with favorable characteristics, including absence of MYCN amplification (89% v 69%; P < .001). In a multivariable analysis, 4N disease remained a significant predictor of outcome (hazard ratio for non-4N v 4N: 3.40 for EFS and 3.69 for OS). Within subgroups defined by age at diagnosis and tumor MYCN status, 4N disease was significantly associated with improved outcomes.
Conclusion
4N represents a subgroup with better outcome than that of other patients with metastatic disease. These findings suggest that the biology and treatment response of 4N tumors differ from other stage 4 tumors, and less intensive therapy should be considered for this cohort. Future exploration of biologic factors determining the pattern of metastatic spread is warranted.
wall of fame sponsors
Please help us by sponsoring one of our children and build our WALL of FAME!! The response to our survey and WALL OF FAME has been overwhelming. We have had over 200 families respond with pictures, drawings, surveys, etc. and they are still rolling in.
Come visit our internet WALL of FAME being built and see our little celebrities, our children. Now we need your help to complete this project. The wall is now complete and we have over 200 children who represent the thousands of U. S. families affected by neuroblastoma. Please help by sponsoring or finding sponsors for these children. If we can raise $2,500 for each child, we will have raised over $250,000, 100% of which will be used for a neuroblastoma research grant.
Let us build this WALL OF FAME and provide HOPE for these children! Together we can make a difference! My tax deductible contribution is enclosed:
Child's Name Donations can be made online through PayPal. Go to our web site at www.neuroblastomacancer.org. gIve neuroblastoma the bIrd
Congress Passes Pediatric Research Laws: A Step Forward for Children with Cancer
The United States Senate approved legislation that will improve research and development of new drugs for children with cancer. "We are pleased that Congress has responded to the pleas of the Children's Cause for Cancer Advocacy urging a more aggressive federal role in encouraging research on life-saving childhood cancer therapies," said Maureen Lilly, executive director of Children's Cause.
The action of the Senate followed House of Representatives approval of legislation renewing the user fee programs for the Food and Drug Administration (FDA) and authorizing additional activities of FDA. The user fee legislation is on its way to President Obama for his signature.
The federal government has for a number of years encouraged, and in some cases, required research on new drugs for all pediatric diseases. The bill permanently reauthorizes the two pediatric research programs, the Pediatric Research Equity Act and the Best Pharmaceuticals for Children Act.
Although the laws have generally worked well in encouraging pediatric research, they have had a limited impact on pediatric cancer drug development. Given these realities, Children's Cause focused in this legislation on the need for the PDA to pay special attention to the benefit of the laws for pediatric cancer research.
"We are very pleased that the door has now been opened for pediatric cancer diseases to receive the special attention they were not receiving before," Lilly said. "We must never forget that pediatric cancer is the number one disease killer of children in the United States."
Children's Cause looks forward to completion of the FDA's report on pediatric research laws and offers its assistance to FDA in its special assessment of the impact of the laws on pediatric cancer drug development.
"We will do all we can to publicize and act on the recommendations of the report and its plan for strengthening the laws and their ability to foster pediatric cancer drug development." Lilly said.
In addition, the legislation approved by Congress also enhances the reporting requirements that are imposed on pharmaceutical companies that experience shortages of drugs. In the past year, children with cancer and their caregivers have suffered through life-threatening shortages of key pediatric cancer therapies. Children's Cause commends Congress for including drug shortages solutions in the user fee legislation and will carefully monitor the benefits of the law's drug shortages provisions.
Children . If you are already ned up for a Thanksgiving race you are welcome to count your race time towards this e as well! register for the event and to share your race time and photos to the event page at tps://www.facebook.com/events/796125667074201/. Prizes awarded for most creative tfits and a general raffle for all participating to win Amazon gift cards! enter submit donation of $30 to PayPal listed at tp://www.neuroblastomacancer.org/donate.php with your address and e-mail address. ery entry received by November 14 th will receive a race bib in the mail along with a epsake towel.
Runners and walkers anywhere in the world are invited! Simply complete 5K distance (3.11 miles) at any time between November 24th and November 29th. If you are already signed up for a Thanksgiving race you are welcome to count your race time towards this one as well! To register for the event and to share your race time and photos to the event page at https://www.facebook. com/events/796125667074201/. Prizes awarded for most creative outfits and a general raffle for all participating to win Amazon gift cards! To enter submit donation of $30 to PayPal at http://www.neuroblastomacancer.org/ donate.php with your address and e-mail address. Every entry received by November 14th will receive a bib in the mail along withwith a keepsake towel.
